Tofacitinib Citrate Intermediate / (3R, 4R) -1-Benzyl-N, 4-Dimethylpiperidine-3-Amino-L- (-) -P-Methyldibenzoyl Tartrate / CAS No. 477600-71-8

• Formula: C34h40n2o8
• Type: Pharmaceutical Intermediates
• Quality: Industrial
• Model NO.: CAS No. 477600-71-8
• Specific Usage: PRO Analysis, for Synthesis
• Content: Standard
• Usage: Laboratory Reagents, Analytical Reagents
• Habit Appellation: Chemical Medicine
• Application: Scientific Research, Health
• Classification: Intermediate of Tofacitinib Citrate
• Grade: Tofacitinib Citrate Intermediate
• Source: Synthesis
• Property: Compounds
• Tofacitinib Citrate: CAS No. 477600-71-8
• Intermediates: Pharmaceutical Intermediates
• Purity: 98%
• Transport Package: Bottle/Barrel
• Specification: 1kg
• Trademark: Xinbell
• Origin: China
• HS Code: 2922500090
• Production Capacity: 1000kg/Year

Product Description

Bis[(3R,4R)-1-Benzyl-N,4-Dimethylpiperidin-3-Amine]di-p-Toluyl-L-Tartrate

Product Description

CAS Number:	477600-71-8
Synonyms:	Butanedioic Acid, 2,3-Bis[(4-Methylbenzoyl)Oxy]-, (2R,3R)-, Compd. With(3R,4R)-N,4-Dimethyl-1-(Phenylmethyl)-3-Piperidinamine (1:2)
	(3R,4R)-1-Benzyl-N,4-Dimethylpiperidin-3-Amine Hemi((2R,3R)-2,3-Bis((4-Methylbenzoyl)Oxy)Succinate)
	(2R,3R)-2,3-Bis[(4-Methylbenzoyl)Oxy]Butanedioic Acid Compd. with (3R,4R)-N,4-Dimethyl-1-(Phenylmethyl)-3-Piperidinamine
	(3R,4R)-1-Benzyl-N,4-Dimethylpiperidine-3-Amino-L-(-)-P-Methyldibenzoyl Tartrate
	(4R)-1-Benzyl-N,4-Dimethylpiperidine-3-Amine 1-Benzyl-N,4-Dimethylpiperidine-3-Amine Half (2R, 3R)
Formula:	C34H40N2O8
Molecular Weight:	604.7
API:	Tofacitinib Citrate

 

Company Profile

 

Nanjing XinBell Pharmaceutical
Technology Co., Ltd.

 is a company specialized in developing, manufacturing and marketing of Active Pharmaceutical ingredients (APIs) and their intermediates. The company also offers Custom Synthesis services. Xinbell has established firmed co-operations with several university and R&D centers. Xinbell provides high quality products, complete documentation and other outstanding supports to the customers. Customers are based in Europe, India, Korea, Japan and other Southeast Asia.

Why Choose Us

Nanjing Xinbell Pharmaceutical Technology Co., Ltd. is a professional company that specializes in developing, manufacturing, and marketing Active Pharmaceutical Ingredients (APIs) and intermediates. We also provide custom synthesis services to meet our clients' personalized needs. With advanced technology and equipment, we ensure our products meet the highest quality standards. Our experienced team provides timely and accurate technical support. Choose Xinbell for innovative solutions and exceptional customer support.

Company Activities

CPHI & PMEC China 2024

Date: June 19-21, 2024

Address: SNIEC, Shanghai, China

API China 2024

Date: May 15-17, 2024

Address: Shanghai, China

API China 2023

Date: April 12-14, 2023

Address: Qingdao World Expo City International Exhibition Center

CPHI China 2023

Date: June 19-21, 2023

Address: SNIEC, Shanghai, China

API China 2022

Date: December 06-08, 2022

Address: Qingdao World Expo City International Exhibition Center

CPhI Worldwide 2022

Date: November 01-03, 2022

Address: Messe Frankfurt, Germany

CPhI India 2022

Date: November 29-December 01, 2022

Address: India Expo Centre, Greater Noida, Delhi NCR

Related products

 

ODM/OEM	Custom Manufacturing
Xinbell offers ODM (Original Design Manufacturer) and OEM (Original Equipment Manufacturer) services to provide customized solutions for their clients.	Xinbell offers Custom Synthesis services to its clients, which involves designing and manufacturing unique chemicals based on their specific requirements.
Fast Shipping	Related products
Xinbell provides fast and reliable shipping services to ensure timely delivery of products to customers. They work with trusted logistics partners.